Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. Vertex Pharmaceuticals Inc leads the sector with a market cap of $110.45 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
Vertex Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
$110.45 Billion | $110.45 Billion | USA | $477.10 | -0.95% | +0.85% | 35.07 Million |
| 2 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
$64.60 Billion | $64.60 Billion | USA | $762.63 | +3.29% | +16.98% | 18.97 Million |
| 3 |
Argen-X
BR:ARGX |
$49.55 Billion | €42.38 Billion | Belgium | €745.00 | -0.21% | -6.52% | 2.09 Million |
| 4 |
UCB SA
BR:UCB |
$47.34 Billion | €40.49 Billion | Belgium | €222.90 | +2.72% | -8.27% | 5.48 Million |
| 5 |
Samsung Biologics Co Ltd
KO:207940 |
$46.59 Billion | ₩68.74 Trillion | Korea | ₩1485000.00 | -2.75% | +7.69% | 1.66 Million |
| 6 |
argenx NV ADR
NASDAQ:ARGX |
$45.97 Billion | $45.97 Billion | USA | $787.95 | -0.66% | -6.29% | 7.48 Million |
| 7 |
UCB S.A. UNSP.ADR 1/2
F:UNC0 |
$44.84 Billion | €38.35 Billion | Germany | €120.00 | -2.44% | -11.11% | 1.13K |
| 8 |
CSL Ltd
AU:CSL |
$42.24 Billion | AU$59.70 Billion | Australia | AU$123.06 | -3.81% | +6.32% | 29.43 Million |
| 9 |
Argen-X
F:1AE |
$41.67 Billion | €35.64 Billion | Germany | €750.00 | -1.24% | -7.22% | 177.00 |
| 10 |
CSL LTD SPON.ADR 2
F:CSJA |
$40.06 Billion | €34.26 Billion | Germany | €18.20 | -3.19% | -9.90% | 420.00 |
| 11 |
Revolution Medicines Inc
NASDAQ:RVMD |
$39.87 Billion | $39.87 Billion | USA | $187.53 | -2.41% | -0.65% | 51.99 Million |
| 12 |
BeiGene, Ltd.
NASDAQ:ONC |
$29.99 Billion | $29.99 Billion | USA | $316.01 | -1.88% | -3.29% | 8.68 Million |
| 13 |
Celltrion Inc
KO:068270 |
$29.02 Billion | ₩42.82 Trillion | Korea | ₩186700.00 | -1.74% | +8.42% | 18.00 Million |
| 14 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
$27.26 Billion | $27.26 Billion | USA | $205.52 | +0.02% | -23.52% | 47.48 Million |
| 15 |
Royalty Pharma Plc
NASDAQ:RPRX |
$25.90 Billion | $25.90 Billion | USA | $58.43 | -1.00% | -1.00% | 63.55 Million |
| 16 |
BeiGene Ltd.
F:49B |
$25.73 Billion | €22.01 Billion | Germany | €17.34 | +0.00% | +0.00% | 0.00 |
| 17 |
Insmed Inc
NASDAQ:INSM |
$21.03 Billion | $21.03 Billion | USA | $98.60 | -2.85% | -8.20% | 56.83 Million |
| 18 |
Roivant Sciences Ltd
NASDAQ:ROIV |
$20.44 Billion | $20.44 Billion | USA | $33.91 | -1.77% | -3.39% | 112.51 Million |
| 19 |
BioNTech SE
F:22UA |
$20.05 Billion | €17.15 Billion | Germany | €78.70 | -2.30% | -0.94% | 9.05K |
| 20 |
Incyte Corporation
NASDAQ:INCY |
$20.04 Billion | $20.04 Billion | USA | $119.52 | -2.82% | +2.43% | 43.88 Million |
| 21 |
Moderna Inc
NASDAQ:MRNA |
$19.49 Billion | $19.49 Billion | USA | $54.82 | -5.35% | -3.86% | 154.38 Million |
| 22 |
Genmab A/S
CO:GMAB |
$17.91 Billion | Dkr114.48 Billion | Denmark | Dkr1858.50 | +0.79% | -2.39% | 2.95 Million |
| 23 |
Innovent Biologics Inc
F:6IB |
$16.76 Billion | €14.34 Billion | Germany | €9.47 | -2.63% | -5.15% | 1.63K |
| 24 |
Genmab AS
NASDAQ:GMAB |
$16.23 Billion | $16.23 Billion | USA | $28.87 | +0.80% | -1.03% | 48.71 Million |
| 25 |
GENMAB AS SP.ADR/1/10DK 1
F:GE91 |
$15.06 Billion | €12.88 Billion | Germany | €23.80 | +3.48% | -2.46% | 68.00 |
| 26 |
WUXI BIOLOGICS UNSP.ADR/2
F:1FW1 |
$14.75 Billion | €12.62 Billion | Germany | €7.20 | -2.04% | -9.43% | 42.00K |
| 27 |
Ascendis Pharma AS
NASDAQ:ASND |
$14.74 Billion | $14.74 Billion | USA | $243.91 | -2.85% | -3.46% | 12.18 Million |
| 28 |
WUXI BIOLOGICS-00000083
F:1FW2 |
$14.60 Billion | €12.49 Billion | Germany | €4.22 | +1.69% | -2.99% | 0.00 |
| 29 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
$14.42 Billion | $14.42 Billion | USA | $80.09 | -2.50% | -3.42% | 78.50 Million |
| 30 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
$14.17 Billion | $14.17 Billion | USA | $252.86 | -2.14% | -0.79% | 16.85 Million |
| 31 |
Ascendis Pharma AS
F:A71 |
$12.65 Billion | €10.82 Billion | Germany | €206.00 | +0.98% | +4.04% | 166.00 |
| 32 |
Exelixis Inc
NASDAQ:EXEL |
$12.17 Billion | $12.17 Billion | USA | $53.03 | -5.25% | -4.71% | 54.21 Million |
| 33 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
$11.90 Billion | $11.90 Billion | USA | $518.74 | -1.97% | +0.03% | 8.60 Million |
| 34 |
Jazz Pharmaceuticals plc
F:J7Z |
$11.86 Billion | €10.14 Billion | Germany | €223.30 | +0.59% | +2.20% | 0.00 |
| 35 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
$11.22 Billion | $11.22 Billion | USA | $217.99 | -7.10% | -9.75% | 17.52 Million |
| 36 |
ALTEOGEN Inc
KQ:196170 |
$11.18 Billion | ₩16.50 Trillion | Korea | ₩308500.00 | +10.38% | +0.65% | 10.97 Million |
| 37 |
AKESO INC. O.N.
F:4RY |
$11.14 Billion | €9.52 Billion | Germany | €10.34 | +0.05% | -8.54% | 1.69K |
| 38 |
Bio-Techne Corp
NASDAQ:TECH |
$11.06 Billion | $11.06 Billion | USA | $72.09 | +0.08% | +0.45% | 127.60 Million |
| 39 |
Avidity Biosciences, Inc
NASDAQ:RNAM |
$11.02 Billion | $11.02 Billion | USA | $71.34 | +0.00% | +0.00% | 0.00 |
| 40 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
$10.93 Billion | $10.93 Billion | USA | $60.02 | -0.92% | +1.95% | 37.19 Million |
| 41 |
Abivax SA American Depositary Shares
NASDAQ:ABVX |
$10.89 Billion | $10.89 Billion | USA | $124.92 | +0.47% | -4.76% | 39.65 Million |
| 42 |
Cytokinetics Inc
NASDAQ:CYTK |
$10.33 Billion | $10.33 Billion | USA | $77.13 | -4.09% | -5.85% | 43.00 Million |
| 43 |
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653 |
$10.22 Billion | CN¥69.86 Billion | China | CN¥62.38 | +3.88% | -13.39% | 406.74 Million |
| 44 |
Summit Therapeutics PLC
NASDAQ:SMMT |
$10.11 Billion | $10.11 Billion | USA | $13.02 | -3.12% | -13.08% | 94.85 Million |
| 45 |
Tubize-Fin
BR:TUB |
$9.59 Billion | €8.20 Billion | Belgium | €194.00 | +2.32% | -6.37% | 435.88K |
| 46 |
Krystal Biotech Inc
NASDAQ:KRYS |
$9.22 Billion | $9.22 Billion | USA | $341.12 | -7.01% | +4.16% | 12.96 Million |
| 47 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
$9.19 Billion | $9.19 Billion | USA | $84.65 | -3.06% | -2.45% | 54.76 Million |
| 48 |
Nuvalent Inc
NASDAQ:NUVL |
$9.12 Billion | $9.12 Billion | USA | $123.96 | +0.00% | +0.13% | 54.40 Million |
| 49 |
Verona Pharma plc
F:I9SA |
$9.07 Billion | €7.76 Billion | Germany | €90.20 | +0.67% | +0.22% | 2.25K |
| 50 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
$8.70 Billion | $8.70 Billion | USA | $82.54 | -0.91% | +2.10% | 41.18 Million |
| 51 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
$8.51 Billion | $8.51 Billion | USA | $103.40 | -3.37% | -6.32% | 16.14 Million |
| 52 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
$8.39 Billion | $8.39 Billion | USA | $51.77 | -2.83% | -7.34% | 96.53 Million |
| 53 |
Blueprint Medicines Corp
NASDAQ:BPMC |
$8.36 Billion | $8.36 Billion | USA | $129.46 | +0.00% | +0.00% | 2.98 Million |
| 54 |
Abivax SA
PA:ABVX |
$8.28 Billion | €7.08 Billion | France | €106.30 | -2.03% | -7.16% | 5.79 Million |
| 55 |
TG Therapeutics Inc
NASDAQ:TGTX |
$7.96 Billion | $7.96 Billion | USA | $52.03 | -2.80% | -6.25% | 50.25 Million |
| 56 |
Pharmaron Beijing Co Ltd
SHE:300759 |
$7.95 Billion | CN¥54.34 Billion | China | CN¥36.80 | +2.19% | -5.64% | 2.14 Billion |
| 57 |
Vaxcyte Inc
NASDAQ:PCVX |
$7.65 Billion | $7.65 Billion | USA | $54.08 | -3.36% | -2.80% | 26.88 Million |
| 58 |
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
$7.44 Billion | CN¥50.82 Billion | China | CN¥152.65 | +4.59% | -6.66% | 354.06 Million |
| 59 |
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
$7.32 Billion | CN¥50.04 Billion | China | CN¥111.20 | -3.77% | -10.73% | 338.12 Million |
| 60 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
$7.31 Billion | $7.31 Billion | USA | $86.00 | +0.00% | -2.27% | 31.77 Million |
| 61 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
$7.08 Billion | $7.08 Billion | USA | $307.83 | +0.03% | -4.52% | 9.22 Million |
| 62 |
ALK-Abelló A/S
CO:ALK-B |
$6.99 Billion | Dkr44.69 Billion | Denmark | Dkr222.00 | -2.20% | -2.80% | 2.87 Million |
| 63 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
$6.96 Billion | $6.96 Billion | USA | $221.38 | +0.03% | +0.26% | 24.25 Million |
| 64 |
Merus BV
NASDAQ:MRUS |
$6.83 Billion | $6.83 Billion | USA | $90.00 | -7.14% | -7.02% | 27.33 Million |
| 65 |
Arcellx Inc
NASDAQ:ACLX |
$6.73 Billion | $6.73 Billion | USA | $115.07 | +0.00% | +0.06% | 44.08 Million |
| 66 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
$6.64 Billion | $6.64 Billion | USA | $98.33 | -3.12% | -1.66% | 27.65 Million |
| 67 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
$6.46 Billion | $6.46 Billion | USA | $105.95 | -5.90% | -7.35% | 15.32 Million |
| 68 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
$6.24 Billion | $6.24 Billion | USA | $134.09 | -0.16% | -0.13% | 37.73 Million |
| 69 |
Belite Bio Inc ADR
NASDAQ:BLTE |
$6.17 Billion | $6.17 Billion | USA | $164.45 | -1.77% | -2.55% | 3.65 Million |
| 70 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
$6.10 Billion | $6.10 Billion | USA | $39.43 | -0.10% | -0.45% | 113.44 Million |
| 71 |
Immunitybio Inc
NASDAQ:IBRX |
$5.96 Billion | $5.96 Billion | USA | $7.17 | -3.76% | -3.11% | 243.96 Million |
| 72 |
Immunovant Inc
NASDAQ:IMVT |
$5.91 Billion | $5.91 Billion | USA | $38.62 | -2.18% | -1.91% | 24.10 Million |
| 73 |
Cogent Biosciences Inc
NASDAQ:COGT |
$5.86 Billion | $5.86 Billion | USA | $38.93 | -5.88% | -3.26% | 54.74 Million |
| 74 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
$5.84 Billion | $5.84 Billion | USA | $99.25 | -6.14% | -3.32% | 15.30 Million |
| 75 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
$5.79 Billion | $5.79 Billion | USA | $71.19 | -2.52% | +0.10% | 22.20 Million |
| 76 |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392 |
$5.66 Billion | CN¥38.69 Billion | China | CN¥30.60 | -0.13% | +4.65% | 139.24 Million |
| 77 |
Erasca Inc
NASDAQ:ERAS |
$5.64 Billion | $5.64 Billion | USA | $18.15 | -2.84% | -6.15% | 113.97 Million |
| 78 |
PTC Therapeutics Inc
NASDAQ:PTCT |
$5.64 Billion | $5.64 Billion | USA | $68.01 | -9.94% | -13.31% | 37.08 Million |
| 79 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
$5.61 Billion | $5.61 Billion | USA | $114.49 | -3.24% | +18.45% | 30.28 Million |
| 80 |
Bachem Holding AG
SW:BANB |
$5.42 Billion | CHF4.29 Billion | Switzerland | CHF74.80 | -2.86% | -0.66% | 3.16 Million |
| 81 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
$5.36 Billion | $5.36 Billion | USA | $106.92 | -5.08% | +2.03% | 22.54 Million |
| 82 |
3SBio Inc
F:83B |
$5.20 Billion | €4.44 Billion | Germany | €1.78 | -3.61% | -4.66% | 2.62K |
| 83 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
$5.09 Billion | $5.09 Billion | USA | $136.64 | -1.44% | +0.89% | 15.03 Million |
| 84 |
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
$5.03 Billion | CN¥34.38 Billion | China | CN¥5.18 | -0.77% | +1.17% | 1.80 Billion |
| 85 |
Suzhou Zelgen Biopharmaceuticals Co Ltd
SHG:688266 |
$4.73 Billion | CN¥32.32 Billion | China | CN¥122.10 | +4.00% | -15.80% | 240.35 Million |
| 86 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
$4.69 Billion | $4.69 Billion | USA | $47.30 | -3.46% | -4.42% | 27.17 Million |
| 87 |
Crispr Therapeutics AG
NASDAQ:CRSP |
$4.63 Billion | $4.63 Billion | USA | $47.99 | -0.93% | +0.97% | 39.88 Million |
| 88 |
Chongqing Zhifei Bio Products
SHE:300122 |
$4.57 Billion | CN¥31.22 Billion | China | CN¥13.04 | +1.09% | +2.84% | 694.91 Million |
| 89 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
$4.55 Billion | $4.55 Billion | USA | $14.49 | +0.00% | +0.21% | 59.70 Million |
| 90 |
CENTESSA PHARMACEUTICALS
F:260 |
$4.54 Billion | €3.88 Billion | Germany | €34.60 | +0.00% | +2.98% | 0.00 |
| 91 |
Akero Therapeutics Inc
NASDAQ:AKRO |
$4.50 Billion | $4.50 Billion | USA | $54.65 | +0.00% | +0.39% | 64.49 Million |
| 92 |
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI |
$4.43 Billion | $4.43 Billion | USA | $15.67 | -2.61% | +0.13% | 84.92 Million |
| 93 |
Sk Biopharmaceuticals Co Ltd
KO:326030 |
$4.19 Billion | ₩6.19 Trillion | Korea | ₩79000.00 | +1.80% | -0.88% | 3.17 Million |
| 94 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
$4.12 Billion | $4.12 Billion | USA | $70.50 | +0.00% | -13.55% | 97.45 Million |
| 95 |
Shanghai Junshi Biosciences Co Ltd
SHG:688180 |
$4.09 Billion | CN¥27.95 Billion | China | CN¥36.51 | +2.15% | -1.88% | 528.37 Million |
| 96 |
Dyne Therapeutics Inc
NASDAQ:DYN |
$4.01 Billion | $4.01 Billion | USA | $25.18 | -2.14% | +5.40% | 61.95 Million |
| 97 |
Celcuity LLC
NASDAQ:CELC |
$4.00 Billion | $4.00 Billion | USA | $86.38 | -1.44% | -2.22% | 38.42 Million |
| 98 |
Camurus AB
ST:CAMX |
$3.96 Billion | Skr36.83 Billion | Sweden | Skr617.50 | -0.56% | +0.41% | 2.04 Million |
| 99 |
Travere Therapeutics Inc
NASDAQ:TVTX |
$3.96 Billion | $3.96 Billion | USA | $55.89 | -2.43% | -1.39% | 31.11 Million |
| 100 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
$3.95 Billion | $3.95 Billion | USA | $83.52 | -0.13% | -0.16% | 178.23 Million |
| 101 |
Veradermics, Incorporated
NYSE:MANE |
$3.94 Billion | $3.94 Billion | USA | $105.00 | +0.35% | -9.37% | 14.27 Million |
| 102 |
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX |
$3.85 Billion | $3.85 Billion | USA | $31.49 | +0.00% | +0.06% | 53.87 Million |
| 103 |
Parabilis Medicines, Inc. Common Stock
NASDAQ:PBLS |
$3.84 Billion | $3.84 Billion | USA | $33.98 | +5.27% | +3.57% | 8.71 Million |
| 104 |
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
$3.71 Billion | CN¥25.37 Billion | China | CN¥12.83 | +0.00% | +3.72% | 394.63 Million |
| 105 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
$3.66 Billion | $3.66 Billion | USA | $25.87 | -2.56% | +4.19% | 34.34 Million |
| 106 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
$3.66 Billion | $3.66 Billion | USA | $38.43 | -6.54% | -2.19% | 24.12 Million |
| 107 |
Hualan Biological EngineeringInc
SHE:002007 |
$3.59 Billion | CN¥24.56 Billion | China | CN¥13.44 | -0.30% | +2.60% | 346.52 Million |
| 108 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
$3.54 Billion | $3.54 Billion | USA | $46.99 | +0.00% | +0.00% | 5.01 Million |
| 109 |
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
$3.49 Billion | CN¥23.82 Billion | China | CN¥58.35 | +0.79% | -1.24% | 98.06 Million |
| 110 |
Legend Biotech Corp
NASDAQ:LEGN |
$3.45 Billion | $3.45 Billion | USA | $18.55 | -2.62% | -21.16% | 54.95 Million |
| 111 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
$3.41 Billion | $3.41 Billion | USA | $48.04 | -2.89% | -5.43% | 15.21 Million |
| 112 |
Tango Therapeutics Inc
NASDAQ:TNGX |
$3.39 Billion | $3.39 Billion | USA | $27.18 | -1.41% | -0.98% | 62.13 Million |
| 113 |
Genscript Biotech Corporation
F:G51 |
$3.36 Billion | €2.88 Billion | Germany | €1.96 | +4.81% | +10.11% | 0.00 |
| 114 |
Hebei Changshan Biochem Pharma
SHE:300255 |
$3.36 Billion | CN¥22.94 Billion | China | CN¥24.96 | +3.53% | -9.04% | 1.38 Billion |
| 115 |
Viking Therapeutics Inc
NASDAQ:VKTX |
$3.35 Billion | $3.35 Billion | USA | $31.74 | -4.14% | -10.31% | 55.38 Million |
| 116 |
Zealand Pharma A/S
CO:ZEAL |
$3.35 Billion | Dkr21.41 Billion | Denmark | Dkr304.00 | -0.30% | +2.39% | 8.20 Million |
| 117 |
Denali Therapeutics Inc
NASDAQ:DNLI |
$3.30 Billion | $3.30 Billion | USA | $23.02 | -5.46% | -1.71% | 40.57 Million |
| 118 |
TELIX Pharmaceuticals Ltd
AU:TLX |
$3.27 Billion | AU$4.62 Billion | Australia | AU$14.21 | +1.00% | -6.33% | 39.51 Million |
| 119 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
$3.24 Billion | $3.24 Billion | USA | $62.67 | -2.37% | -4.20% | 29.65 Million |
| 120 |
Arcus Biosciences Inc
NYSE:RCUS |
$3.19 Billion | $3.19 Billion | USA | $28.19 | -0.21% | -5.18% | 23.27 Million |
| 121 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
$3.15 Billion | $3.15 Billion | USA | $27.79 | -2.35% | -9.03% | 22.31 Million |
| 122 |
Alumis Inc
NASDAQ:ALMS |
$3.01 Billion | $3.01 Billion | USA | $28.25 | -2.42% | -0.18% | 33.02 Million |
| 123 |
Celldex Therapeutics Inc
NASDAQ:CLDX |
$2.99 Billion | $2.99 Billion | USA | $38.06 | -1.10% | +7.45% | 24.03 Million |
| 124 |
Relay Therapeutics Inc
NASDAQ:RLAY |
$2.95 Billion | $2.95 Billion | USA | $18.83 | -3.19% | -1.36% | 65.20 Million |
| 125 |
Soleno Therapeutics Inc
NASDAQ:SLNO |
$2.76 Billion | $2.76 Billion | USA | $53.01 | +0.00% | +0.11% | 48.81 Million |
| 126 |
HLB Co. Ltd
KQ:028300 |
$2.76 Billion | ₩4.07 Trillion | Korea | ₩30600.00 | +2.17% | +2.00% | 30.10 Million |
| 127 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
$2.69 Billion | $2.69 Billion | USA | $287.54 | -2.95% | -4.84% | 8.20 Million |
| 128 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
$2.65 Billion | $2.65 Billion | USA | $26.86 | -4.04% | -1.72% | 29.95 Million |
| 129 |
Beam Therapeutics Inc
NASDAQ:BEAM |
$2.63 Billion | $2.63 Billion | USA | $25.52 | -3.66% | -1.51% | 55.88 Million |
| 130 |
Disc Medicine Inc.
NASDAQ:IRON |
$2.61 Billion | $2.61 Billion | USA | $77.00 | -2.79% | +1.50% | 11.32 Million |
| 131 |
BioArctic AB (publ)
ST:BIOA-B |
$2.60 Billion | Skr24.13 Billion | Sweden | Skr325.00 | +0.62% | +5.93% | 2.53 Million |
| 132 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
$2.59 Billion | $2.59 Billion | USA | $18.25 | -0.82% | +6.23% | 58.70 Million |
| 133 |
Immunome Inc
NASDAQ:IMNM |
$2.54 Billion | $2.54 Billion | USA | $22.76 | -1.39% | +3.41% | 28.87 Million |
| 134 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
$2.54 Billion | $2.54 Billion | USA | $59.04 | -0.84% | +0.79% | 27.88 Million |
| 135 |
Kodiak Sciences Inc
NASDAQ:KOD |
$2.51 Billion | $2.51 Billion | USA | $41.58 | -2.16% | +1.37% | 16.00 Million |
| 136 |
ABL Bio Inc
KQ:298380 |
$2.50 Billion | ₩3.68 Trillion | Korea | ₩66800.00 | +9.87% | -10.09% | 9.28 Million |
| 137 |
BB Biotech AG
SW:BION |
$2.48 Billion | CHF1.96 Billion | Switzerland | CHF51.10 | -1.73% | +2.40% | 2.17 Million |
| 138 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
$2.47 Billion | $2.47 Billion | USA | $35.50 | -2.47% | -2.01% | 22.79 Million |
| 139 |
Enliven Therapeutics Inc.
NASDAQ:ELVN |
$2.46 Billion | $2.46 Billion | USA | $54.81 | +1.59% | +3.79% | 21.59 Million |
| 140 |
Ultragenyx
NASDAQ:RARE |
$2.45 Billion | $2.45 Billion | USA | $24.91 | -4.34% | -7.81% | 50.29 Million |
| 141 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
$2.43 Billion | $2.43 Billion | USA | $22.57 | -6.66% | +1.17% | 67.03 Million |
| 142 |
Nektar Therapeutics
NASDAQ:NKTR |
$2.38 Billion | $2.38 Billion | USA | $70.67 | -1.09% | +1.89% | 21.13 Million |
| 143 |
Pharma Reaserch Prod Co Ltd
KQ:214450 |
$2.38 Billion | ₩3.52 Trillion | Korea | ₩338500.00 | -2.73% | -5.97% | 5.31 Million |
| 144 |
SOLENO THERAPEUT. DL-001
F:6XC |
$2.31 Billion | €1.97 Billion | Germany | €44.86 | +1.70% | +1.20% | 130.00 |
| 145 |
Vera Therapeutics Inc
NASDAQ:VERA |
$2.30 Billion | $2.30 Billion | USA | $32.10 | -2.87% | -11.69% | 53.20 Million |
| 146 |
KEYMED BIOSCIENCES -0001
F:64Z |
$2.28 Billion | €1.95 Billion | Germany | €8.00 | +0.00% | -15.34% | 0.00 |
| 147 |
Sinocelltech Group Ltd
SHG:688520 |
$2.21 Billion | CN¥15.07 Billion | China | CN¥33.85 | +2.11% | -6.23% | 90.56 Million |
| 148 |
89bio Inc
NASDAQ:ETNB |
$2.20 Billion | $2.20 Billion | USA | $14.84 | +0.00% | +0.27% | 140.50 Million |
| 149 |
Kailera Therapeutics, Inc. Common Stock
NASDAQ:KLRA |
$2.19 Billion | $2.19 Billion | USA | $16.94 | -0.65% | -2.64% | 14.37 Million |
| 150 |
LegoChem Biosciences Inc
KQ:141080 |
$2.16 Billion | ₩3.19 Trillion | Korea | ₩87500.00 | +12.32% | -13.96% | 10.83 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries